106 related articles for article (PubMed ID: 10077438)
1. Biodisposition characteristics of N-succinyl-chitosan and glycol-chitosan in normal and tumor-bearing mice.
Kamiyama K; Onishi H; Machida Y
Biol Pharm Bull; 1999 Feb; 22(2):179-86. PubMed ID: 10077438
[TBL] [Abstract][Full Text] [Related]
2. Biological fate of highly-succinylated N-succinyl-chitosan and antitumor characteristics of its water-soluble conjugate with mitomycin C at i.v. and i.p. administration into tumor-bearing mice.
Kato Y; Onishi H; Machida Y
Biol Pharm Bull; 2000 Dec; 23(12):1497-503. PubMed ID: 11145185
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of N-succinyl-chitosan as a systemic long-circulating polymer.
Kato Y; Onishi H; Machida Y
Biomaterials; 2000 Aug; 21(15):1579-85. PubMed ID: 10885730
[TBL] [Abstract][Full Text] [Related]
4. Biodegradation and distribution of water-soluble chitosan in mice.
Onishi H; Machida Y
Biomaterials; 1999 Jan; 20(2):175-82. PubMed ID: 10022787
[TBL] [Abstract][Full Text] [Related]
5. Lactosaminated and intact N-succinyl-chitosans as drug carriers in liver metastasis.
Kato Y; Onishi H; Machida Y
Int J Pharm; 2001 Sep; 226(1-2):93-106. PubMed ID: 11532574
[TBL] [Abstract][Full Text] [Related]
6. N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates.
Kato Y; Onishi H; Machida Y
Biomaterials; 2004 Feb; 25(5):907-15. PubMed ID: 14609679
[TBL] [Abstract][Full Text] [Related]
7. Biological characteristics of lactosaminated N-succinyl-chitosan as a liver-specific drug carrier in mice.
Kato Y; Onishi H; Machida Y
J Control Release; 2001 Feb; 70(3):295-307. PubMed ID: 11182200
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of lactosaminated and intact N-succinylchitosan-mitomycin C conjugates against M5076 liver metastatic cancer.
Kato Y; Onishi H; Machida Y
J Pharm Pharmacol; 2002 Apr; 54(4):529-37. PubMed ID: 11999131
[TBL] [Abstract][Full Text] [Related]
9. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
Sato M; Onishi H; Takahara J; Machida Y; Nagai T
Biol Pharm Bull; 1996 Sep; 19(9):1170-7. PubMed ID: 8889036
[TBL] [Abstract][Full Text] [Related]
10. In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles.
Yan C; Gu J; Guo Y; Chen D
Yakugaku Zasshi; 2010 Jun; 130(6):801-4. PubMed ID: 20519858
[TBL] [Abstract][Full Text] [Related]
11. Preparation of CM-chitin microspheres by complexation with iron(III) in w/o emulsion and their biodisposition characteristics in mice.
Hata H; Onishi H; Machida Y
Biomaterials; 2000 Sep; 21(17):1779-88. PubMed ID: 10905460
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and drug-release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethyl-chitin.
Song Y; Onishi H; Nagai T
Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2822-5. PubMed ID: 1464115
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic characteristics and antitumor activity of the N-succinyl-chitosan-mitomycin C conjugate and the carboxymethyl-chitin-mitomycin C conjugate.
Song Y; Onishi H; Nagai T
Biol Pharm Bull; 1993 Jan; 16(1):48-54. PubMed ID: 8369752
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect.
Son YJ; Jang JS; Cho YW; Chung H; Park RW; Kwon IC; Kim IS; Park JY; Seo SB; Park CR; Jeong SY
J Control Release; 2003 Aug; 91(1-2):135-45. PubMed ID: 12932645
[TBL] [Abstract][Full Text] [Related]
15. Application of chitin and chitosan derivatives in the pharmaceutical field.
Kato Y; Onishi H; Machida Y
Curr Pharm Biotechnol; 2003 Oct; 4(5):303-9. PubMed ID: 14529420
[TBL] [Abstract][Full Text] [Related]
16. Bioadhesive characteristics of chitosan microspheres to the mucosa of rat small intestine.
Shimoda J; Onishi H; Machida Y
Drug Dev Ind Pharm; 2001 Jul; 27(6):567-76. PubMed ID: 11548864
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and biodegradation mechanisms of a versatile carboxymethyl derivative of chitosan in rats: in vivo and in vitro evaluation.
Dong W; Han B; Feng Y; Song F; Chang J; Jiang H; Tang Y; Liu W
Biomacromolecules; 2010 Jun; 11(6):1527-33. PubMed ID: 20459052
[TBL] [Abstract][Full Text] [Related]
18. Contribution of chitosan and its derivatives to cancer chemotherapy.
Kato Y; Onishi H; Machida Y
In Vivo; 2005; 19(1):301-10. PubMed ID: 15796190
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.
Yan C; Chen D; Gu J; Qin J
J Pharm Pharmacol; 2006 Sep; 58(9):1177-81. PubMed ID: 16945175
[TBL] [Abstract][Full Text] [Related]
20. Preparation and drug release characteristics of the conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
Sato M; Onishi H; Kitano M; Machida Y; Nagai T
Biol Pharm Bull; 1996 Feb; 19(2):241-5. PubMed ID: 8850315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
